MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
Despite limited clinical efficacy, treatment with dacarbazine or temozolomide (TMZ) remains the standard therapy for metastatic melanoma. In glioblastoma, promoter methylation of the counteracting DNA repair enzyme O6-methylguanine-DNA-methyltransferase (MGMT) correlates with survival of patients ex...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
24 August 2010
|
| In: |
British journal of cancer
Year: 2010, Volume: 103, Issue: 6, Pages: 820-826 |
| ISSN: | 1532-1827 |
| DOI: | 10.1038/sj.bjc.6605796 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.bjc.6605796 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/6605796 
|
| Author Notes: | J.C. Hassel, A. Sucker, L. Edler, H. Kurzen, I. Moll, C. Stresemann, K. Spieth, C. Mauch, K. Rass, R. Dummer and D. Schadendorf on behalf of DeCOG |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1840190388 | ||
| 003 | DE-627 | ||
| 005 | 20230710144942.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230327s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/sj.bjc.6605796 |2 doi | |
| 035 | |a (DE-627)1840190388 | ||
| 035 | |a (DE-599)KXP1840190388 | ||
| 035 | |a (OCoLC)1389806981 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hassel, Jessica C. |d 1975- |e VerfasserIn |0 (DE-588)129790702 |0 (DE-627)480399069 |0 (DE-576)29783715X |4 aut | |
| 245 | 1 | 0 | |a MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome |c J.C. Hassel, A. Sucker, L. Edler, H. Kurzen, I. Moll, C. Stresemann, K. Spieth, C. Mauch, K. Rass, R. Dummer and D. Schadendorf on behalf of DeCOG |
| 264 | 1 | |c 24 August 2010 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.03.2023 | ||
| 520 | |a Despite limited clinical efficacy, treatment with dacarbazine or temozolomide (TMZ) remains the standard therapy for metastatic melanoma. In glioblastoma, promoter methylation of the counteracting DNA repair enzyme O6-methylguanine-DNA-methyltransferase (MGMT) correlates with survival of patients exposed to TMZ in combination with radiotherapy. For melanoma, data are limited and controversial. | ||
| 650 | 4 | |a Cancer therapeutic resistance | |
| 650 | 4 | |a Melanoma | |
| 650 | 4 | |a Predictive markers | |
| 700 | 1 | |a Sucker, Antje |e VerfasserIn |0 (DE-588)1161138153 |0 (DE-627)1024540596 |0 (DE-576)506375412 |4 aut | |
| 700 | 1 | |a Edler, Lutz |d 1945- |e VerfasserIn |0 (DE-588)143483293 |0 (DE-627)646571796 |0 (DE-576)167028103 |4 aut | |
| 700 | 1 | |a Kurzen, Hjalmar |e VerfasserIn |0 (DE-588)1076780180 |0 (DE-627)835325016 |0 (DE-576)18792581X |4 aut | |
| 700 | 1 | |a Moll, I. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stresemann, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Spieth, K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mauch, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rass, K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dummer, R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of cancer |d Edinburgh : Nature Publ. Group, 1947 |g 103(2010), 6 vom: Aug., Seite 820-826 |h Online-Ressource |w (DE-627)320420094 |w (DE-600)2002452-6 |w (DE-576)103746854 |x 1532-1827 |7 nnas |a MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome |
| 773 | 1 | 8 | |g volume:103 |g year:2010 |g number:6 |g month:08 |g pages:820-826 |g extent:7 |a MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome |
| 856 | 4 | 0 | |u https://doi.org/10.1038/sj.bjc.6605796 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/6605796 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230327 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 11 |y j | ||
| 998 | |g 1076780180 |a Kurzen, Hjalmar |m 1076780180:Kurzen, Hjalmar |d 60000 |e 60000PK1076780180 |k 0/60000/ |p 4 | ||
| 998 | |g 143483293 |a Edler, Lutz |m 143483293:Edler, Lutz |d 50000 |e 50000PE143483293 |k 0/50000/ |p 3 | ||
| 998 | |g 129790702 |a Hassel, Jessica C. |m 129790702:Hassel, Jessica C. |d 910000 |d 911300 |e 910000PH129790702 |e 911300PH129790702 |k 0/910000/ |k 1/910000/911300/ |p 1 |x j | ||
| 999 | |a KXP-PPN1840190388 |e 4298150046 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"family":"Hassel","display":"Hassel, Jessica C.","given":"Jessica C.","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Sucker, Antje","family":"Sucker","role":"aut","given":"Antje"},{"family":"Edler","display":"Edler, Lutz","role":"aut","given":"Lutz","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Hjalmar","display":"Kurzen, Hjalmar","family":"Kurzen","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","given":"I.","role":"aut","family":"Moll","display":"Moll, I."},{"roleDisplay":"VerfasserIn","role":"aut","given":"C.","family":"Stresemann","display":"Stresemann, C."},{"roleDisplay":"VerfasserIn","family":"Spieth","display":"Spieth, K.","given":"K.","role":"aut"},{"display":"Mauch, C.","family":"Mauch","given":"C.","role":"aut","roleDisplay":"VerfasserIn"},{"role":"aut","given":"K.","display":"Rass, K.","family":"Rass","roleDisplay":"VerfasserIn"},{"family":"Dummer","display":"Dummer, R.","role":"aut","given":"R.","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","given":"Dirk","role":"aut","display":"Schadendorf, Dirk","family":"Schadendorf"}],"recId":"1840190388","origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"24 August 2010"}],"title":[{"title":"MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome","title_sort":"MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome"}],"name":{"displayForm":["J.C. Hassel, A. Sucker, L. Edler, H. Kurzen, I. Moll, C. Stresemann, K. Spieth, C. Mauch, K. Rass, R. Dummer and D. Schadendorf on behalf of DeCOG"]},"id":{"doi":["10.1038/sj.bjc.6605796"],"eki":["1840190388"]},"physDesc":[{"extent":"7 S."}],"note":["Gesehen am 27.03.2023"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"pubHistory":["Volume 1, issue 1 (1 March 1947)-"],"id":{"eki":["320420094"],"zdb":["2002452-6"],"issn":["1532-1827"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 27.10.25"],"part":{"extent":"7","volume":"103","year":"2010","text":"103(2010), 6 vom: Aug., Seite 820-826","issue":"6","pages":"820-826"},"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"BJC"}],"recId":"320420094","disp":"MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcomeBritish journal of cancer","origin":[{"publisherPlace":"Edinburgh ; Edinburgh","dateIssuedDisp":"1947-","publisher":"Nature Publ. Group ; Churchill Livingstone","dateIssuedKey":"1947"}],"language":["eng"],"title":[{"title":"British journal of cancer","subtitle":"BJC","title_sort":"British journal of cancer"}]}]} | ||
| SRT | |a HASSELJESSMGMTGENEPR2420 | ||